Mikhail S Drenichev

11PUBLICATIONS
27CO-AUTHORS
Biologically active moleculesMolecular targetsPlant developmental and reproductive biologyCheminformatics and quantitative structure-activity relationshipsGlycobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 28, 2026
Chiral-Modified Nucleoside Analogues: From Bioactivity to Therapeutic Applications.

|Oct 29, 2025
Validating TDP1 as an Inhibition Target for Lipophilic Nucleoside Derivative in Human Cells.

Irina A Chernyshova, Tatyana E Kornienko, Nadezhda S Dyrkheeva

|Sep 12, 2025
The Arabidopsis TIRome informs the design of artificial TIR (Toll/interleukin-1 receptor) domain proteins.

Adam M Bayless, Lijiang Song, Mitchell Sorbello

|Oct 28, 2023
Nucleoside Analog 2',3'-Isopropylidene-5-Iodouridine as Novel Efficient Inhibitor of HIV-1.

Ksenia Glumakova, Georgy Ivanov, Valeria Vedernikova

|Apr 20, 2023
Purine Nucleosides and Analogues Bearing Chiral Substituents: Medicinal Chemistry and Therapeutic Perspective.

Mikhail S Drenichev, Valentina N Borokh

|Jan 08, 2023
The Lipophilic Purine Nucleoside-Tdp1 Inhibitor-Enhances DNA Damage Induced by Topotecan In Vitro and Potentiates the Antitumor Effect of Topotecan In Vivo.

Irina A Chernyshova, Aleksandra L Zakharenko, Nikolay N Kurochkin

Pageof 2

Frequent Collaborators

7 joint publications

Vladimir Oslovsky

4 joint publications

Olga I Lavrik

3 joint publications

Sergey N Mikhailov

3 joint publications

Nadezhda S Dyrkheeva